We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QUCY
176
Quantum Cyber N.V.
QUCY
$31.4M
$631K 0.01%
196,600
-25,400
-11% -$133K
GROY.WS icon
177
Gold Royalty Corp Warrants
GROY.WS
$157M
$550K 0.01%
2,200,000
– –
MNTS icon
178
Momentus
MNTS
$82.7M
$528K 0.01%
14,803
+2,632
+22% +$201K
AEMD icon
179
Aethlon Medical
AEMD
$1.59M
$511K 0.01%
+3,570
New +$831K
SPGI icon
180
S&P Global
SPGI
$119B
$511K 0.01%
+1,005
New +$514K
DHAI
181
DELISTED
DIH Holdings US
DHAI
$481K 0.01%
+83,120
New +$1.54M
INTC icon
182
Intel
INTC
$503B
$468K 0.01%
+20,603
New +$451K
DRMA icon
183
Dermata Therapeutics
DRMA
$4.46M
$444K 0.01%
41,100
+38,380
+1,411% +$472K
EVGN icon
184
Evogene
EVGN
$8.29M
$395K 0.01%
316,024
+17,743
+6% +$26.8K
PWCM
185
PowerCompute, Inc. Common Stock
PWCM
$1.46M
$384K 0.01%
12,400
-2,320
-16% -$102K
BGMS
186
Bio Green Med Solution Inc
BGMS
$5.35M
$354K 0.01%
5,290
+2,871
+119% +$235K
BKYI
187
BIO-key International
BKYI
$4.33M
$348K 0.01%
+44,046
New +$560K
IVP
188
DELISTED
Inspire Veterinary Partners
IVP
$347K 0.01%
+202,896
New +$528K
CELZ icon
189
Creative Medical Technology
CELZ
$7.46M
$321K ﹤0.01%
+148,000
New +$516K
KMTS
190
Kestra Medical Technologies
KMTS
$1.48B
$312K ﹤0.01%
+12,500
New +$287K
IPDN icon
191
Professional Diversity Network
IPDN
$5.49M
$285K ﹤0.01%
113,453
+1,557
+1% +$5.37K
MTEKW icon
192
Maris-Tech Ltd Warrants
MTEKW
$277K ﹤0.01%
1,261,058
– –
LLY icon
193
Eli Lilly
LLY
$1.06T
$260K ﹤0.01%
+315
New +$262K
BEATW icon
194
Heartbeam Inc Warrant
BEATW
$255K ﹤0.01%
500,000
– –
IDAI icon
195
T Stamp
IDAI
$17.5M
$252K ﹤0.01%
+130,000
New +$445K
NXGLW icon
196
NexGel Inc Warrant
NXGLW
$250K ﹤0.01%
550,000
– –
ASMB icon
197
Assembly Biosciences
ASMB
$524M
$228K ﹤0.01%
23,858
-144,216
-86% -$1.89M
CERO
198
DELISTED
CERo Therapeutics
CERO
$228K ﹤0.01%
+15,600
New +$616K
STKH
199
Steakholder Foods
STKH
$1.51M
$164K ﹤0.01%
1,325
+30
+2% +$5.21K
ELAN icon
200
Elanco Animal Health
ELAN
$12.1B
$138K ﹤0.01%
+13,105
New +$148K
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.